Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.24

-0.16

-0.08

0

Details

Expected EPS

-0.193007

Actual EPS

-0.22

Surprise EPS

-0.03

Surprise Percent

+13.99%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.22 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.